Chemoinformaics analysis of 3,5-Di-tert-butylcatechol
| Molecular Weight | 222.328 | nRot | 0 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 6 |
| Exact Molecular Weight | 222.162 | nRing | 1 |
| Solubility: LogS | -4.1 | nHRing | 0 |
| Solubility: LogP | 4.346 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 39.6534 |
| nHD | 2 | BPOL | 22.0706 |
| QED | 0.657 |
| Synth | 2.248 |
| Natural Product Likeliness | 0.271 |
| NR-PPAR-gamma | 0.897 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.642 |
| Pgp-sub | 0.008 |
| HIA | 0.812 |
| CACO-2 | -4.985 |
| MDCK | 0.0000124 |
| BBB | 0.163 |
| PPB | 0.982875 |
| VDSS | 5.197 |
| FU | 0.0563381 |
| CYP1A2-inh | 0.826 |
| CYP1A2-sub | 0.924 |
| CYP2c19-inh | 0.396 |
| CYP2c19-sub | 0.421 |
| CYP2c9-inh | 0.504 |
| CYP2c9-sub | 0.811 |
| CYP2d6-inh | 0.847 |
| CYP2d6-sub | 0.809 |
| CYP3a4-inh | 0.29 |
| CYP3a4-sub | 0.523 |
| CL | 6.848 |
| T12 | 0.721 |
| hERG | 0.011 |
| Ames | 0.015 |
| ROA | 0.13 |
| SkinSen | 0.927 |
| Carcinogencity | 0.033 |
| EI | 0.963 |
| Respiratory | 0.702 |
| NR-Aromatase | 0.086 |
| Antiviral | Yes |
| Prediction | 0.812325 |